Back to Stakeholders

US-based API CDMO with stated capabilities for Schedule I psychedelic compounds, supporting clinical trial supply and cGMP manufacturing workflows.

Manufacturing Snapshot

Established CDMO / Manufacturer

Scope & Capabilities

API ProductionCDMO ServicesAnalytical / QC TestingRegulatory / CMC Support

Supply Use Cases

Clinical TrialsResearch UseCommercial / Licensed Supply

GxP / Compliance

cGMPDEA Controlled-Substance Compliance

Facilities & Access

Athens, Georgia API manufacturing and CDMO operation with controlled-substance specialization.

Manufacturing Details

Supported Substances

Psilocybin, psilocin, MDMA derivatives, LSD, DMT derivatives, ketamine, and ibogaine (as listed by company).

Regulatory Authorizations

1 authorization

United States - FDA / DEA

Active

FDA-inspected and DEA-licensed facilities

View source

Quick Facts

Website
Visit